CCK2 receptors in chronic pain

被引：6
|
作者：
LaVigne, Justin E. [1 ]
Alles, Sascha R. A. [1 ]
机构：
[1] Univ New Mexico, Sch Med, Dept Anesthesiol & Crit Care Med, Albuquerque, NM 87109 USA
来源：
NEUROBIOLOGY OF PAIN | 2022年 / 11卷
关键词：
CCK2; Cholecystokinin; Chronic pain; Non-opioid treatment; PREVENTS MORPHINE-TOLERANCE; ANTAGONIST L-365,260; CHOLECYSTOKININ-OCTAPEPTIDE; B RECEPTOR; SPINAL CHOLECYSTOKININ; SELECTIVE ANTAGONIST; INDUCED HYPERALGESIA; INDUCED ANALGESIA; OPIOID ANALGESIA; NEUROPATHIC PAIN;
D O I：
10.1016/j.ynpai.2022.100092
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The cholecystokinin receptor system, specifically cholecystokinin 2 receptor (CCK2R) is a historic target for pain management that has shown limited success. However, new approaches to target CCK2R have incited fresh enthusiasm for this target. In this mini-review, we discuss what is known about CCK2R in peripheral and central circuits under na & iuml;ve physiological conditions and under conditions of chronic pain, the interactions of CCK2Rs with opioids and briefly, recent efforts to develop new treatments targeting CCK2R for chronic pain.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Acquisition of analgesic properties by the cholecystokinin (CCK)/CCK2 receptor system within the amygdala in a persistent inflammatory pain condition
    Roca-Lapirot, Olivier
    Fossat, Pascal
    Ma, Sherie
    Egron, Karine
    Trigilio, Gabriella
    Lopez-Gonzalez, Maria-Jose
    Covita, Joao
    Bouali-Benazzouz, Rabia
    Favereaux, Alexandre
    Gundlach, Andrew L.
    Landry, Marc
    PAIN, 2019, 160 (02) : 345 - 357
  • [22] Process development of the CCK2 receptor ligand
    Anzalone, Luigi
    Abdel-Magid, Ahmed F.
    Cohen, Judith
    Mehrman, Steven
    Villani, Frank J., Jr.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233
  • [23] Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK2) Receptors by Novel Bivalent Ligands
    Zheng, Yaguo
    Akgun, Eyup
    Harikumar, Kaleeckal G.
    Hopson, Jessika
    Powers, Michael D.
    Lunzer, Mary M.
    Miller, Laurence J.
    Portoghese, Philip S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) : 247 - 258
  • [24] Involvement of CCK2 receptor in food intake regulation: Hyperphagia and increased fat deposition in CCK2 receptor-deficient mice
    Clerc, P.
    Broussaud, S.
    Coll, Maria Gracia
    Lulka, Hubert
    Leung-Theung-Long, S.
    Matsui, T.
    Seva, C.
    Fourmy, D.
    Dufresne, M.
    REGULATORY PEPTIDES, 2006, 135 (03) : 121 - 121
  • [25] Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors
    Morton, MF
    Liu, PQ
    Reik, A
    de la Rosa, R
    Mendel, M
    Li, XY
    Case, C
    Pabo, C
    Moreno, V
    Pyati, J
    Shankley, NP
    REGULATORY PEPTIDES, 2005, 129 (1-3) : 227 - 232
  • [26] Computer modelling of new pseudopeptide CCK2 agonists
    Tairi-Kellou, S
    Bellier, B
    Million, ME
    Garbay, C
    Cartier, A
    Maigret, B
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2002, 589 : 55 - 66
  • [27] CCK2 receptor as a therapeutic target for neuroendocrine tumours
    Stubbs, M
    Khan, K
    Savage, K
    McStay, M
    Dhillon, AP
    Caplin, ME
    ENDOCRINE-RELATED CANCER, 2003, 10 (04) : 505 - 505
  • [28] Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors:: New implications for the pathophysiology of panic
    Sánchez-Fernández, C
    González, C
    Mercer, LD
    Beart, PM
    Ruiz-Gayo, M
    Fernández-Alfonso, MS
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (03): : 364 - 370
  • [29] CCK2 receptor-deficient mice have increased sensitivity of dopamine D2 receptors
    Koks, S
    Abramov, U
    Veraksits, A
    Bourin, M
    Matsui, T
    Vasar, E
    NEUROPEPTIDES, 2003, 37 (01) : 25 - 29
  • [30] CCK2 receptor as a therapeutic target for neuroendocrine tumours
    Stubbs, M
    Khan, K
    Savage, K
    McStay, M
    Dhillon, AP
    Caplin, ME
    GUT, 2003, 52 : A29 - A30
12345